Kimia Biosciences Ltd

NSE: BSE: 530313

₹33.56

+0.84 (2.57%)

Thu, 22 Oct 2026, 06:54 pm

MTF 5xInvest in Kimia Biosciences Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)154.81

PE Ratio22.10

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Kimia Biosciences Financials

Income Statement Balance Sheet Cashflow

Particulars	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total revenue	64.46M	17.47M	1.92M	14.60M	588.65M	939.17M	1.07B	1.33B	1.25B	1.28B	1.04B	1.18B
Gross profit	-314.43K	-20.74M	-27.51M	-4.18M	62.76M	92.98M	93.17M	117.64M	48.57M	21.17M	34.84M	236.86M
Operating expenses (excl. COGS)	-7.11M	-2.79M	-9.22M	-7.54M	-22.34M	-46.35M	-52.39M	-52.96M	-73.71M	-92.68M	-77.18M	-72.93M
Selling/general/admin expenses, total	-6.83M	-2.57M	-8.55M	-4.03M	-20.07M	-42.88M	-50.82M	-52.34M	-72.76M	-91.53M	-76.99M	-71.28M
Research & development	—	—	—	—	—	-28.42M	-41.82M	-61.60M	-63.79M	—	-50.19M	—
Selling/general/admin expenses, other	-6.83M	-2.57M	-8.55M	-4.03M	-20.07M	-14.46M	-9.00M	9.26M	-8.97M	-91.53M	-26.81M	-71.28M
Other operating expenses, total	-285.17K	-220.51K	-666.28K	-3.52M	-2.26M	-3.48M	-1.58M	-616.00K	-944.00K	-1.15M	-184.00K	-1.64M
Operating income	-7.43M	-23.54M	-36.73M	-11.72M	40.42M	46.62M	40.78M	64.68M	-25.14M	-71.51M	-42.33M	163.94M
Non-operating income, total	-495.54K	6.56M	-3.70M	1.67M	142.00K	-8.56M	-28.52M	-9.34M	-25.04M	-52.37M	-29.50M	-27.60M
Interest expense, net of interest capitalized	-844.38K	-404.46K	-5.57M	-2.69M	-1.99M	-19.96M	-25.29M	-33.90M	-36.41M	-42.45M	-45.70M	-40.34M
Interest capitalized	0	0	0	0	0	1.24M	2.29M	3.59M	854.00K	0	0	0
Non-operating income, excl. interest expenses	348.84K	2.24M	759.16K	4.36M	1.94M	11.24M	-3.47M	24.13M	11.35M	529.00K	12.58M	12.75M
Non-operating interest income	17.01K	19.60K	24.10K	19.00K	669.00K	12.71M	650.00K	536.00K	311.00K	293.00K	325.00K	218.00K
Miscellaneous non-operating expense	331.83K	2.22M	735.06K	4.34M	1.27M	-1.47M	-4.12M	23.60M	11.04M	236.00K	12.26M	12.53M
Unusual income/expense	0	4.73M	1.11M	0	191.00K	158.00K	241.00K	428.00K	20.00K	-10.45M	3.62M	0
Pretax income	-7.92M	-16.98M	-40.44M	-10.06M	40.56M	38.06M	12.26M	55.34M	-50.18M	-123.88M	-71.84M	136.34M
Taxes	77.19K	-52.33K	-91.94K	761.00K	0	493.00K	1.55M	-4.30M	13.15M	30.36M	18.75M	-40.22M
Non-controlling/minority interest	0	0	0	0	0	0	0	0	0	0	0	0
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	-7.85M	-17.03M	-40.53M	-9.29M	40.56M	38.55M	13.81M	51.04M	-37.03M	-93.52M	-53.09M	96.12M
Net income	-7.85M	-17.03M	-40.53M	-9.29M	40.56M	38.55M	13.81M	51.04M	-37.03M	-93.52M	-53.09M	96.12M
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	40.00K	40.00K	—	0	0	0	0	0
Diluted net income available to common stockholders	-7.85M	-17.03M	-40.53M	-9.29M	40.52M	38.51M	13.81M	51.04M	-37.03M	-93.52M	-53.09M	96.12M
Basic earnings per share (Basic EPS)	-1.06	-2.31	-5.49	-1.26	5.49	2.64	0.33	1.08	-0.78	-1.98	-1.12	2.03
Diluted earnings per share (Diluted EPS)	-1.06	-2.31	-5.49	-1.26	5.42	1.39	0.29	1.08	-0.78	-1.98	-1.12	2.03
EBITDA	-2.96M	-19.18M	-33.80M	-8.25M	46.16M	57.60M	57.38M	83.79M	4.27M	-38.19M	-9.41M	197.73M
EBIT	-7.43M	-23.54M	-36.73M	-11.72M	40.42M	46.62M	40.78M	64.68M	-25.14M	-71.51M	-42.33M	163.94M
Total operating expenses	-71.89M	-41.01M	-38.66M	-26.32M	-548.23M	-892.55M	-1.03B	-1.26B	-1.27B	-1.35B	-1.09B	-1.02B
Prepaid expenses	4.44M	3.84M	2.75M	702.00K	635.00K	1.33M	3.20M	2.62M	3.15M	1.42M	1.31M	2.15M
Deferred income, current	127.55K	1.18M	23.32K	23.00K	468.00K	—	—	6.14M	16.99M	23.07M	15.03M	37.92M
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	1.84M	2.76M
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	4.00M	3.75M	3.80M	3.36M	—	8.92M	—	11.92M	15.73M	18.70M	19.69M	21.11M
Deferred income, non-current	295.53K	174.78K	0	—	—	40.96M	43.59M	28.47M	23.47M	18.48M	13.47M	8.48M
Minority interest	0	0	0	0	0	0	0	0	0	0	0	0
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends paid	0	0	0	0	—	—	—	0	0	0	0	0

Particulars	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total revenue	64.46M	17.47M	1.92M	14.60M	588.65M	939.17M	1.07B	1.33B	1.25B	1.28B	1.04B	1.18B
Gross profit	-314.43K	-20.74M	-27.51M	-4.18M	62.76M	92.98M	93.17M	117.64M	48.57M	21.17M	34.84M	236.86M
Operating expenses (excl. COGS)	-7.11M	-2.79M	-9.22M	-7.54M	-22.34M	-46.35M	-52.39M	-52.96M	-73.71M	-92.68M	-77.18M	-72.93M
Selling/general/admin expenses, total	-6.83M	-2.57M	-8.55M	-4.03M	-20.07M	-42.88M	-50.82M	-52.34M	-72.76M	-91.53M	-76.99M	-71.28M
Research & development	—	—	—	—	—	-28.42M	-41.82M	-61.60M	-63.79M	—	-50.19M	—
Selling/general/admin expenses, other	-6.83M	-2.57M	-8.55M	-4.03M	-20.07M	-14.46M	-9.00M	9.26M	-8.97M	-91.53M	-26.81M	-71.28M
Other operating expenses, total	-285.17K	-220.51K	-666.28K	-3.52M	-2.26M	-3.48M	-1.58M	-616.00K	-944.00K	-1.15M	-184.00K	-1.64M
Operating income	-7.43M	-23.54M	-36.73M	-11.72M	40.42M	46.62M	40.78M	64.68M	-25.14M	-71.51M	-42.33M	163.94M
Non-operating income, total	-495.54K	6.56M	-3.70M	1.67M	142.00K	-8.56M	-28.52M	-9.34M	-25.04M	-52.37M	-29.50M	-27.60M
Interest expense, net of interest capitalized	-844.38K	-404.46K	-5.57M	-2.69M	-1.99M	-19.96M	-25.29M	-33.90M	-36.41M	-42.45M	-45.70M	-40.34M
Interest capitalized	0	0	0	0	0	1.24M	2.29M	3.59M	854.00K	0	0	0
Non-operating income, excl. interest expenses	348.84K	2.24M	759.16K	4.36M	1.94M	11.24M	-3.47M	24.13M	11.35M	529.00K	12.58M	12.75M
Non-operating interest income	17.01K	19.60K	24.10K	19.00K	669.00K	12.71M	650.00K	536.00K	311.00K	293.00K	325.00K	218.00K
Miscellaneous non-operating expense	331.83K	2.22M	735.06K	4.34M	1.27M	-1.47M	-4.12M	23.60M	11.04M	236.00K	12.26M	12.53M
Unusual income/expense	0	4.73M	1.11M	0	191.00K	158.00K	241.00K	428.00K	20.00K	-10.45M	3.62M	0
Pretax income	-7.92M	-16.98M	-40.44M	-10.06M	40.56M	38.06M	12.26M	55.34M	-50.18M	-123.88M	-71.84M	136.34M
Taxes	77.19K	-52.33K	-91.94K	761.00K	0	493.00K	1.55M	-4.30M	13.15M	30.36M	18.75M	-40.22M
Non-controlling/minority interest	0	0	0	0	0	0	0	0	0	0	0	0
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	-7.85M	-17.03M	-40.53M	-9.29M	40.56M	38.55M	13.81M	51.04M	-37.03M	-93.52M	-53.09M	96.12M
Net income	-7.85M	-17.03M	-40.53M	-9.29M	40.56M	38.55M	13.81M	51.04M	-37.03M	-93.52M	-53.09M	96.12M
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	40.00K	40.00K	—	0	0	0	0	0
Diluted net income available to common stockholders	-7.85M	-17.03M	-40.53M	-9.29M	40.52M	38.51M	13.81M	51.04M	-37.03M	-93.52M	-53.09M	96.12M
Basic earnings per share (Basic EPS)	-1.06	-2.31	-5.49	-1.26	5.49	2.64	0.33	1.08	-0.78	-1.98	-1.12	2.03
Diluted earnings per share (Diluted EPS)	-1.06	-2.31	-5.49	-1.26	5.42	1.39	0.29	1.08	-0.78	-1.98	-1.12	2.03
EBITDA	-2.96M	-19.18M	-33.80M	-8.25M	46.16M	57.60M	57.38M	83.79M	4.27M	-38.19M	-9.41M	197.73M
EBIT	-7.43M	-23.54M	-36.73M	-11.72M	40.42M	46.62M	40.78M	64.68M	-25.14M	-71.51M	-42.33M	163.94M
Total operating expenses	-71.89M	-41.01M	-38.66M	-26.32M	-548.23M	-892.55M	-1.03B	-1.26B	-1.27B	-1.35B	-1.09B	-1.02B
Prepaid expenses	4.44M	3.84M	2.75M	702.00K	635.00K	1.33M	3.20M	2.62M	3.15M	1.42M	1.31M	2.15M
Deferred income, current	127.55K	1.18M	23.32K	23.00K	468.00K	—	—	6.14M	16.99M	23.07M	15.03M	37.92M
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	1.84M	2.76M
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	4.00M	3.75M	3.80M	3.36M	—	8.92M	—	11.92M	15.73M	18.70M	19.69M	21.11M
Deferred income, non-current	295.53K	174.78K	0	—	—	40.96M	43.59M	28.47M	23.47M	18.48M	13.47M	8.48M
Minority interest	0	0	0	0	0	0	0	0	0	0	0	0
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends paid	0	0	0	0	—	—	—	0	0	0	0	0